Two Sigma Investments
BBP icon

Two Sigma Investments’s Virtus Biotech ETF BBP Stock Holding History

Two Sigma Investments’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$914K Hold
11,000
– – ﹤0.01% 3328
2025
Q4 		$879K Buy
+11,000
New +$835K ﹤0.01% 3012

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return

Two Sigma Investments's BBP Position: Q1 2026 in Review

Two Sigma Investments held its Virtus Biotech ETF (BBP) position steady in Q1 2026 at 11,000 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Two Sigma Investments first reported a position in BBP in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Two Sigma Investments held 11,000 shares of Virtus Biotech ETF worth $914K as of Q1 2026.
  • Two Sigma Investments left its Virtus Biotech ETF share count unchanged in Q1 2026.
  • Virtus Biotech ETF made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3328 holding.
  • Two Sigma Investments first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.